Clinical Trials | April 22, 2026
Merck wins FDA priority review for KEYTRUDA bladder cancer combo expansion
If approved, the move would significantly broaden the use of KEYTRUDA and KEYTRUDA QLEX in combination with Padcev
If approved, the move would significantly broaden the use of KEYTRUDA and KEYTRUDA QLEX in combination with Padcev
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
Targets high-growth eye care expansion push
Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materials
Policy symposium in Hyderabad focuses on life skills education and community?driven solutions
Manoj has over two decades of experience in healthcare operations and biomedical engineering
Inspection outcome reinforces company's compliance track record and strengthens its ability to serve regulated markets including the United States
The programme integrates simulation-based training, expert-led sessions, and case-based discussions
The plant is currently scaling towards a production capacity of nearly 3 million gloves per day
The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints
Subscribe To Our Newsletter & Stay Updated
